Pharmacyte Biotech Inc (OTCMKTS:PMCB) Regains Some Lost Value

[[tagnumber 0]][[tagnumber 1]]After a good climb in the end of the first quarter and the beginning of the second managed to push the stock of Pharmacyte Biotech Inc (OTCMKTS:PMCB) above the 20 cent per share mark we saw the ticker begin to slide down the charts, losing more than 50% of its value by the beginning of this month.[[tagnumber 2]] [[tagnumber 0]]In fact, the company stock has lost so much altitude that it recently hit another 52–week low of $0.72 per share. Meanwhile, the financials of [[tagnumber 4]]PMCB[[tagnumber 5]] aren‘t that bad compared to other companies traded on the OTC marketplace. Here is an example of what the company had to show in the end of July this year.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 9]] [[tagnumber 10]]cash: $2.9 million[[tagnumber 11]] [[tagnumber 10]]current assets: $3.01 million[[tagnumber 11]] [[tagnumber 10]]current liabilities: $1.1 million[[tagnumber 11]] [[tagnumber 10]]revenues: ZERO[[tagnumber 11]] [[tagnumber 10]]loss from operations: $1 million[[tagnumber 11]] [[tagnumber 20]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The cash positions of [[tagnumber 4]]PMCB[[tagnumber 5]] are pretty decent. The problem is that the company is far from commercializing a revenues–generating product. As we have previously written the company is still preparing to start Phase 2b of the clinical trials for its pancreatic cancer treatment.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The most recent press release came on Friday and it announced that [[tagnumber 4]]PMCB[[tagnumber 5]] have hired Chamow & Associates in order to help the with Chemistry, Manufacturing and Control (CMC) regulatory requirements before the company can initiate the Phase 2b trial.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]This managed to provide the company stock with a green close of the week. The news pushed PMCB 10.42% up the charts and we saw the ticker close at a price of $0.0795 while a total of 2 million shares changed their owners and generated $158 thousand in daily dollar volume.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The hype might transfer into this week as we see that [[tagnumber 4]]PMCB[[tagnumber 5]] Is 6.92% up minutes after the market open. Still, that doesn‘t mean that you should skip doing your due diligence and weighing out the risks before putting any money on the line.[[tagnumber 2]]